VOYAGER CENCT07696182
Validation Of anatomY-specific Aortic Valve Implantation Guided by Software Using EncantoR
StatusNot Yet Recruiting
PhaseNot applicable
SponsorAbbott Medical Devices
Primary completion (estimated)
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗
- Notable Enrollment increased: 150 → 300 participants
- Eligibility criteria expanded, about 7 words
- Trial sites expanded: 0 → 36 locations
- Interventions modified
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Composite of all-cause mortality or all strokes at 12 months post index
Timeframe: 12 months post index
Arms and interventions
Encantor TAVI SystemExperimental
The Encantor System is intended to treat patients with symptomatic severe aortic stenosis via transcatheter aortic valve implantation (TAVI)
Devices: Transcatheter valve replacement therapy
Sites
36 sites in 8 countries
Germany 11, Australia 7, France 6, Italy 5, Spain 3, Sweden 2, Norway 1, Portugal 1